JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC
What was lobbied
10 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
- Issues related to ADAP funding. - Issues related to FDA funding. - Issues related to Alzheimer's funding. - Issues related to deficit reductions/ fiscal cliff
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BURNS | — |
| JULIE D COHEN | — |
| DARREL C JODREY | — |
| CHARLES NAU | — |
| MARK REESE | — |
Torts TOR
- HR 5, "Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011", regarding all provisions. - HR 675, "Strengthening Medicare Anti-Fraud Measures Act of 2011", regarding all provisions. - Issues regarding Health Courts
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY ARONIN | — |
| BRIAN BURNS | — |
Trade (domestic/foreign) TRD
- Korea-US Free Trade Agreement - Issues related to current and future trade negotiations. - TransPacific Partnership trade negotiations. - Pending legislation regarding the extension of permanent normal trade relations to Russia.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID KAVANAUGH | — |
Financial Institutions/Investments/Securities FIN
- HR 1062, "The Burdensome Data Collection Relief Act", regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID KAVANAUGH | — |
Taxation/Internal Revenue Code TAX
- Issues regarding tax reform. - HR 605, "The Patients' Freedom to Choose Act", regarding all provisions. - HR 436, "Protect Medical Innovation Act of 2011", regarding all provisions. - HR 488, "Save Our Medical Devices Act of 2011", regarding all provisions. - HR 734, "To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes", regarding all provisions. - S 17, "Medical Device Access and Innovation Protection Act", regarding all provisions. - S 262, "A bill to repeal the excise tax on medical device manufacturers", regarding all provisions. - HR 942, "American Research and Competitiveness Act of 2011", regarding all provisions - Issues related to tax legislation. - Issues related to the President's proposed "Job Bill" (2011) - S 1368/ HR 2529, "Restoring Access to Medication Act", regarding all provisions. - S 1584, "Drug Safety and Accountability Act of 2011", regarding all provisions. - HR 2245, "Preserving Access to Life-Saving Medication Act", regarding all provisions. - Issues related to Ways and Means tax reform discussion draft. - HR 2735, "To amend the Internal Revenue Code of 1986 to make permanent the look-through treatment of payments between related controlled foreign corporations", regarding all provisions. - S 1577, "Greater Research Opportunities With Tax Help Act", regarding all provisions. - PL 112-96, "Middle Class Tax Relief and Job Creation Act of 2012", provisions regarding Medicare clinical laboratory services. - HR 1864, "Mobile Workforce State Income Tax Simplification Act of 2011", regarding all provisions. - S 2091, "United States Job Creation and International Tax Reform Act of 2012", regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| DON BOHN | — |
| BRIAN BURNS | — |
| JULIE D COHEN | — |
| KIMBERLY DAVIS | — |
| DARREL C JODREY | — |
| DAVID KAVANAUGH | — |
Health Issues HCR
- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - Issues related to Physician Payment Sunshine provisions. - Issues related to the "Regulation & Reimbursement of Diagnostics", regarding all provisions. - Implementation of the Health Care Reform Bill, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 2960, "National Diabetes Clinical Care Commission Act", regarding all provisions. - HR 3026, "Safeguarding America's Pharmaceutical Act of 2011", regarding all provisions. - Prescription Drug User Fee Act, regarding all provisions - Personalized Medicine Incentives and Regulation. - Issues related to Alzheimer's research. - HR 2939, "Pharmaceutical Stewardship Act of 2011", regarding all provisions. - HR 3497, "MODERN Cures Act of 2011", regarding all provisions. - HR 3207, "Modernizing Laboratory Test Standards for Patients Act of 2011", regarding all provisions. - S 1700, "Medical Device Regulatory Improvement Act", regarding all provisions. - S 1865, "Patient Access to Medical Innovation Act", regarding all provisions. - S 1995, "Medical Device Patient Safety Act", regarding all provisions. - Issues related to vision care coverage under PPACA. - Medical Device User Fee Act Reauthorization. - HR 1483, "The Drug Safety Enhancement Act of 2011", regarding all provisions. - HR 3847, "Safety of Untested and New Devices Act of 2012", regarding all provisions. - HR 3975, "A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007", regarding all provisions. - S 2113, "A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve public health." regarding all provisions. - S 2193, "Ensuring Safe Medical Devices for Patients", regarding all provisions. - HR 5, "Protecting Access to Healthcare (PATH) Act", regarding all provisions. - HR 452, "Medicare Decisions Accountability Act of 2011", regarding all provisions. - Issues related to the repeal and/or reform of Independent Payment Advisory Boards. - HR 5937, "Breast Cancer Patient Education Act of 2012", regarding all provisions. - HR 5998, "USPSTF Transparency and Accountability Act of 2012", regarding all provisions. - S 3187, "Food and Drug Administration Safety and Innovation Act", regarding all provisions. - S 2516, "Food and Drug Administration Safety and Innovation Act", regarding all provisions. - HR 6584, Verifying Authority and Legality In Drug Compounding Act of 2012, regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| GREGORY ARONIN | — |
| DON BOHN | — |
| BRIAN BURNS | — |
| JULIE D COHEN | — |
| KIMBERLY DAVIS | — |
| LAURYL DODSON JACKSON | — |
| DARREL C JODREY | — |
| CHARLES NAU | — |
| MARK REESE | — |
Medicare/Medicaid MMM
- HR 905/ S 733, "To Amend Part B or Title XVIII of the Social Security Act to exclude customary prompt pay discounts from Manufacturers to Wholesalers from the average sales price for drugs & biologicals under Medicare", regarding all provisions. - HR 1041, "The Fairness in Medicare Bidding Act", regarding all provisions. - Issues related to Medicare reimbursement for Clinical Laboratory Services. - HR 1041, "Fairness in Medicare Bidding Act", regarding all provisions. - Medicare Part D Letter - HR 452, "Medicare Decisions Accountability Act of 2011", regarding all provisions. - S 668, "Health Care Bureaucrats Elimination Act", regarding all provisions. - Issues related to Physician-owned Companies that manufacture or distribute medical devices. - S 1468/ HR 2787, "Medicare Diabetes Self-Management Training Act of 2011", regarding all provisions. - PL 112-96, "Middle Class Tax Relief and Job Creation Act of 2012", provisions regarding Medicare clinical laboratory services. - Issues related to implantable medical devices. - HR 5998, "USPSTF Transparency and Accountability Act of 2012", regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE D COHEN | — |
| KIMBERLY DAVIS | — |
| LAURYL DODSON JACKSON | — |
| MARK REESE | — |
Environment/Superfund ENV
- Issues related to chemicals in the environment - Issues related to the Toxic Substances Control Act - S. 847, "Safe Chemicals Act of 2011", regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY ARONIN | — |
| DARREL C JODREY | — |
Consumer Issues/Safety/Products CSP
- Issues related to dextromethorphan - Issues related to Pseudoephedrine - Issues related to the regulation of Cosmetic Products. - HR 2359, "Safe Cosmetics Act of 2011", regarding all provisions. - HR 4395, "Cosmetic Safety Amendments Act of 2012", regarding all provisions. - HR 4262, "Cosmetic Safety Enhancement Act of 2012", regarding all provisions. - S 3376, "Prevent Abuse of Cough Treatment Act of 2012", regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY ARONIN | — |
| DON BOHN | — |
| DARREL C JODREY | — |
Law Enforcement/Crime/Criminal Justice LAW
- Issues regarding the theft of medical products. - S 1002, "SAFE DOSES Act", regarding all provisions. - HR 4223, "Safe Doses Act", regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK REESE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.